HK Stock MarketDetailed Quotes
03759 PHARMARON
- 13.220
- -0.560-4.06%
Trading Oct 17 15:10 CST
23.63BMarket Cap11.18P/E (TTM)
14.220High13.140Low9.60MVolume14.000Open13.780Pre Close132.01MTurnover3.19%Turnover Ratio13.38P/E (Static)1.79BShares24.85052wk High1.66P/B3.99BFloat Cap7.98052wk Low0.22Dividend TTM301.54MShs Float93.548Historical High0.220Dividend LFY7.84%Amplitude7.980Historical Low13.747Avg Price100Lot Size1.66%Div YieldTTM1.66%Div Yield LFY
PHARMARON Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 35.04%1.23B | ---- | 10.29%1.84B | ---- | 22.33%908.53M | ---- | -12.80%1.67B | ---- | 11.53%742.7M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 44.77%-1.13M | ---- | 88.15%-2.3M | ---- | 85.72%-2.04M | ---- | 28.74%-19.42M | ---- | -28.16%-14.32M | ---- |
| Investment loss (gain) | ---- | ---- | -96.79%70K | ---- | -95.16%70K | ---- | 129.05%2.18M | ---- | 124.43%1.45M | ---- |
| Attributable subsidiary (profit) loss | 375.97%30.31M | ---- | -93.84%2.08M | ---- | -347.40%-10.98M | ---- | 147.12%33.85M | ---- | -36.52%4.44M | ---- |
| Impairment and provisions: | 64.53%22.19M | ---- | 77.04%44.39M | ---- | 51.87%13.49M | ---- | 91.24%25.07M | ---- | 1,038.72%8.88M | ---- |
| -Impairmen of inventory (reversal) | -126.91%-747K | ---- | 118.69%8.57M | ---- | 9.16%2.78M | ---- | 37.83%3.92M | ---- | 103.12%2.54M | ---- |
| -Other impairments and provisions | 114.13%22.94M | ---- | 69.33%35.83M | ---- | 69.00%10.71M | ---- | 106.03%21.16M | ---- | 1,443.01%6.34M | ---- |
| Revaluation surplus: | 84.10%-8.34M | ---- | 55.24%-46.34M | ---- | 34.66%-52.42M | ---- | 64.10%-103.53M | ---- | -365.82%-80.23M | ---- |
| -Other fair value changes | 84.10%-8.34M | ---- | 55.24%-46.34M | ---- | 34.66%-52.42M | ---- | 64.10%-103.53M | ---- | -365.82%-80.23M | ---- |
| Asset sale loss (gain): | -3,393.73%-541.91M | ---- | 79.27%-14.65M | ---- | -9,388.02%-15.51M | ---- | -22.11%-70.66M | ---- | -80.85%167K | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 33,810.34%29.5M | ---- | -39.90%1.09M | ---- | -47.90%87K | ---- | 14.28%1.82M | ---- | -80.85%167K | ---- |
| -Loss (gain) from selling other assets | -3,563.39%-571.42M | ---- | 78.28%-15.74M | ---- | ---15.6M | ---- | -21.90%-72.48M | ---- | ---- | ---- |
| Depreciation and amortization: | 15.18%554.81M | ---- | 31.66%1.01B | ---- | 41.50%481.69M | ---- | 32.61%766.06M | ---- | 26.41%340.42M | ---- |
| -Amortization of intangible assets | 9.61%18.88M | ---- | 12.76%35.62M | ---- | 14.24%17.23M | ---- | 28.31%31.59M | ---- | 24.55%15.08M | ---- |
| Financial expense | 55.29%138.25M | ---- | 8.89%182.19M | ---- | 9.60%89.03M | ---- | 101.40%167.31M | ---- | 414.60%81.24M | ---- |
| Exchange Loss (gain) | -163.02%-46.49M | ---- | -222.67%-199.15M | ---- | 352.39%73.77M | ---- | 728.53%162.35M | ---- | 442.42%16.31M | ---- |
| Special items | -112.51%-15.42M | ---- | 13.18%196.84M | ---- | 139.03%123.27M | ---- | 158.39%173.93M | ---- | 100.51%51.57M | ---- |
| Operating profit before the change of operating capital | -15.52%1.36B | ---- | 7.35%3.01B | ---- | 39.58%1.61B | ---- | 26.35%2.8B | ---- | 15.99%1.15B | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -3,899.30%-119.49M | ---- | 92.19%-12.47M | ---- | 104.13%3.15M | ---- | -225.71%-159.73M | ---- | -180.98%-76.08M | ---- |
| Accounts receivable (increase)decrease | 119.53%40.75M | ---- | 42.07%-377.6M | ---- | 37.24%-208.6M | ---- | -313.99%-651.86M | ---- | -462.30%-332.41M | ---- |
| Accounts payable increase (decrease) | 97.32%-8.6M | ---- | -35.24%238.58M | ---- | -232.04%-321.11M | ---- | 12.70%368.42M | ---- | 2,028.74%243.19M | ---- |
| prepayments (increase)decrease | 416.78%91.07M | ---- | -249.88%-17M | ---- | 4.31%-28.75M | ---- | 93.63%-4.86M | ---- | 46.57%-30.04M | ---- |
| Special items for working capital changes | -108.40%-32.95M | ---- | 2,546.30%202.84M | ---- | 1,118.90%392.03M | ---- | -60.97%7.67M | ---- | -43.53%32.16M | ---- |
| Cash from business operations | -8.00%1.33B | ---- | 28.81%3.04B | ---- | 46.10%1.45B | ---- | 3.53%2.36B | ---- | 7.59%989.44M | ---- |
| Other taxs | -39.18%-230.19M | ---- | -31.79%-290.42M | ---- | -26.58%-165.39M | ---- | 1.89%-220.36M | ---- | -75.20%-130.66M | ---- |
| Adjustment items of business operations | ---- | 40.65%745.63M | ---- | 45.47%2.03B | ---- | 26.89%530.14M | ---- | -1.46%1.4B | ---- | -16.27%417.79M |
| Net cash from operations | -14.10%1.1B | 40.65%745.63M | 28.50%2.75B | 45.47%2.03B | 49.07%1.28B | 26.89%530.14M | 4.12%2.14B | -1.46%1.4B | 1.62%858.79M | -16.27%417.79M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | -61.26%5.75M | ---- | -33.26%36.54M | ---- | -38.74%14.84M | ---- | -11.12%54.75M | ---- | 144.64%24.23M |
| Decrease in deposits (increase) | -98.26%1.43M | ---- | -87.88%82.3M | ---- | -85.79%82.04M | ---- | 560.88%679.12M | ---- | 226.87%577.23M | ---- |
| Sale of fixed assets | -68.10%267K | -85.88%81.18K | 157.15%8.11M | 523.51%6.48M | -14.94%837K | -32.13%574.83K | 118.49%3.16M | -27.84%1.04M | -3.91%984K | 222.46%846.99K |
| Purchase of fixed assets | 37.74%-930.68M | 36.47%-498.62M | 2.48%-2.85B | -1.88%-2.24B | -14.85%-1.49B | -16.56%-784.84M | -40.23%-2.92B | -42.05%-2.2B | -26.13%-1.3B | -22.94%-673.31M |
| Purchase of intangible assets | -223.27%-19.53M | ---- | 41.48%-17.25M | ---- | 52.38%-6.04M | ---- | -186.63%-29.47M | ---- | -297.56%-12.69M | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | 16.62%-1.02B | 11.12%-908.87M | 34.50%-568.02M | -6,645.08%-474.92M |
| Recovery of cash from investments | 14.65%2.09B | -30.14%1.11B | -24.91%2.57B | -46.63%2.06B | -41.58%1.82B | -31.08%1.58B | 47.14%3.42B | 25.16%3.87B | 11.06%3.12B | 215.11%2.3B |
| Cash on investment | -0.18%-1.42B | -56.20%-1.08B | 12.50%-2.04B | 20.28%-1.67B | 18.54%-1.41B | 56.73%-691.37M | 44.50%-2.34B | 57.43%-2.1B | 36.58%-1.74B | 10.68%-1.6B |
| Other items in the investment business | -24.13%145.92M | ---- | 127.40%597K | ---667.5K | 241.95%192.33M | ---- | -102.40%-2.18M | ---- | -322.66%-135.5M | ---- |
| Net cash from investment operations | 84.03%-130.65M | -483.54%-467.09M | -1.91%-2.25B | -40.82%-1.81B | -1,335.79%-817.94M | 128.67%121.78M | 58.00%-2.21B | 70.50%-1.28B | 97.44%-56.97M | 73.53%-424.83M |
| Net cash before financing | 109.64%969.09M | -57.27%278.54M | 864.85%502.71M | 99.19%221.54M | -42.35%462.27M | 9,361.30%651.92M | 97.95%-65.73M | 103.79%111.22M | 158.11%801.82M | 99.36%-7.04M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -14.59%222.19M | 61.90%104.09M | 616.01%4.17B | 83.86%491.84M | 121.79%260.15M | -16.88%64.3M | -31.09%582.52M | -94.05%267.51M | -79.76%117.3M | -79.54%77.35M |
| Refund | 73.03%-96.35M | -34,909.81%-1.51B | 8.76%-559.14M | 17.81%-468.1M | 28.96%-357.23M | 97.10%-4.31M | -286.52%-612.85M | -372.50%-569.5M | -513.60%-502.82M | -556.47%-148.81M |
| Issuing shares | ---- | ---- | 137.65%17.33M | ---- | ---- | ---- | -99.81%7.29M | ---- | ---- | ---- |
| Interest paid - financing | -249.28%-94.39M | ---- | -72.93%-87.44M | ---- | -10.05%-27.03M | ---- | -7.20%-50.57M | ---- | -22.28%-24.56M | ---- |
| Dividends paid - financing | ---295.11M | -224.59%-46.3M | -4.70%-370.84M | -1.03%-395.12M | ---- | -6.54%-14.27M | -49.10%-354.19M | -43.76%-391.09M | -29.89%-301.12M | -51.71%-13.39M |
| Absorb investment income | ---- | ---- | ---- | --953.25M | --860M | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | -516,466.99%-4.29B | ---- | 99.79%-830K | ---- | 99.60%-830K | ---- | -33.10%-393.38M | ---- | -435.68%-207.15M | ---- |
| Other items of the financing business | ---- | -30.14%-60.34M | 357.54%953.25M | 74.12%-150.39M | ---- | 78.26%-46.37M | -364.02%-370.14M | -96.90%-580.99M | ---16.44M | -246.96%-213.26M |
| Net cash from financing operations | -825.39%-4.65B | -232,823.73%-1.51B | 376.26%3.92B | 133.87%431.49M | 160.10%641.46M | 99.78%-649.4K | -138.71%-1.42B | -133.44%-1.27B | -127.10%-1.07B | -204.59%-298.11M |
| Effect of rate | 374.59%57.63M | 131.48%6.46M | -84.34%11.43M | -88.12%10.11M | -68.13%12.14M | 2.49%-20.51M | 260.37%72.99M | 599.77%85.06M | 502.25%38.11M | -482.85%-21.03M |
| Net Cash | -433.77%-3.68B | -289.48%-1.23B | 397.91%4.42B | 156.16%653.02M | 515.81%1.1B | 313.43%651.27M | -421.49%-1.48B | -233.05%-1.16B | -110.38%-265.44M | 62.82%-305.15M |
| Begining period cash | 325.76%5.79B | 325.76%5.79B | -50.91%1.36B | -50.91%1.36B | -50.91%1.36B | -50.91%1.36B | 17.66%2.77B | 17.66%2.77B | 17.66%2.77B | 17.66%2.77B |
| Cash at the end | -12.63%2.16B | 129.17%4.56B | 325.76%5.79B | 19.56%2.02B | -2.63%2.48B | -18.54%1.99B | -50.91%1.36B | -47.31%1.69B | -48.14%2.54B | 59.76%2.44B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data